Regulatory Story
Company Centrica PLC
Headline Statement regarding Centrica Chairman
Released 14:00 12-Feb-2020
Number 8014C

RNS Number : 8014C
Centrica PLC
12 February 2020

12th February 2020


Centrica plc


('The Company')


Board Announcement


Statement regarding Charles Berry, Centrica Chairman


Centrica plc (the 'Company') announces that, due to an unanticipated medical condition, the Company's Chairman, Charles Berry, is taking a leave of absence.


We wish him well and expect him to return to his duties shortly. Until his return, Scott Wheway will be acting as interim Chairman.






Investors/analysts               01753 494900           

Media                                   01784 843000           




Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.